A phase II study of efficacy and safety of Pegasys in patients with Chronic Phase Chronic Myeloid Leukaemia in PCR+ve complete or near complete cytogenetic remission on Glivec at 600 mg daily or maximum tolerated dose (CML07)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-phase-ii-dose-cml07/2538336
下载链接
链接失效反馈官方服务：
资源简介：
Dataset includes data for 21 patients with newly diagnosed CML Combination of Pegasys and Glivec treatment demographic data diagnostic data treatment data outcome data
提供机构：
Health Data Australia Contributor Records
